Clinical Trial Update: Novel Protective Underglove [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a novel protective underglove for preventing bacterial infections; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Diseases

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Bacterial Diseases | Phase 2 | Status: COMPLETED